| Literature DB >> 21556319 |
Eva Petkova1, Thaddeus Tarpey, Usha Govindarajulu.
Abstract
Non-specific responses to treatment (commonly known as placebo response) are pervasive when treating mental illness. Subjects treated with an active drug may respond in part due to non-specific aspects of the treatment, i.e, those not related to the chemical effect of the drug. To determine the extent a subject responds due to the chemical effect of a drug, one must disentangle the specific drug effect from the non-specific placebo effect. This paper presents a unique statistical model that allows for the separate prediction of a specific effect and non-specific effects in drug treated subjects. Data from a clinical trial comparing fluoxetine to a placebo for treating depression is used to illustrate this methodology.Entities:
Keywords: BLUP; allometric extension; linear mixed effects models; longitudinal outcome; non-specific treatment effect; principal components; specific drug effect
Mesh:
Substances:
Year: 2009 PMID: 21556319 PMCID: PMC3085382 DOI: 10.2202/1557-4679.1152
Source DB: PubMed Journal: Int J Biostat ISSN: 1557-4679 Impact factor: 0.968